Aida Pharmaceuticals AIDA Stock
Aida Pharmaceuticals Price Chart
Aida Pharmaceuticals AIDA Financial and Trading Overview
| Aida Pharmaceuticals stock price | 0.0003 USD |
| Previous Close | 0.0003 USD |
| Open | 0.0002 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0002 - 0.0002 USD |
| 52 Week Range | 0.0002 - 0.0003 USD |
| Volume | 2K USD |
| Avg. Volume | 0 USD |
| Market Cap | 12.56M USD |
| Beta (5Y Monthly) | 22.419 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AIDA Valuation Measures
| Enterprise Value | 41.09M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.3099608 |
| Price/Book (mrq) | 0.0008849558 |
| Enterprise Value/Revenue | 1.014 |
| Enterprise Value/EBITDA | 4.319 |
Trading Information
Aida Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 22.419 |
| 52-Week Change | 50.00% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.0003 USD |
| 52 Week Low | 0.0002 USD |
| 50-Day Moving Average | 0.0003 USD |
| 200-Day Moving Average | 0.0002545 USD |
AIDA Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 0 |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 5:4 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2007 |
| Most Recent Quarter (mrq) | September 30, 2008 |
| Next Fiscal Year End | December 31, 2008 |
Profitability
| Profit Margin | -5.37% |
| Operating Margin (ttm) | 21.29% |
| Gross Margin | 55.06% |
| EBITDA Margin | 23.48% |
Management Effectiveness
| Return on Assets (ttm) | 6.62% |
| Return on Equity (ttm) | -1.78% |
Income Statement
| Revenue (ttm) | 40.51M USD |
| Revenue Per Share (ttm) | 1.5 USD |
| Quarterly Revenue Growth (yoy) | 61.19% |
| Gross Profit (ttm) | 22.3M USD |
| EBITDA | 9.51M USD |
| Net Income Avi to Common (ttm) | -2178529 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | 341.10% |
Balance Sheet
| Total Cash (mrq) | 8.28M USD |
| Total Cash Per Share (mrq) | 0.31 USD |
| Total Debt (mrq) | 41.17M USD |
| Total Debt/Equity (mrq) | 237.46 USD |
| Current Ratio (mrq) | 0.728 |
| Book Value Per Share (mrq) | 0.339 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 7.49M USD |
| Levered Free Cash Flow (ttm) | 2.27M USD |
Profile of Aida Pharmaceuticals
| Country | United States |
| State | N/A |
| City | Hangzhou |
| Address | 31 Dingjiang Road |
| ZIP | 310016 |
| Phone | 86 571 8580 2712 |
| Website | N/A |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 450 |
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.
Q&A For Aida Pharmaceuticals Stock
What is a current AIDA stock price?
Aida Pharmaceuticals AIDA stock price today per share is 0.0003 USD.
How to purchase Aida Pharmaceuticals stock?
You can buy AIDA shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aida Pharmaceuticals?
The stock symbol or ticker of Aida Pharmaceuticals is AIDA.
Which industry does the Aida Pharmaceuticals company belong to?
The Aida Pharmaceuticals industry is Drug Manufacturers - Specialty & Generic.
How many shares does Aida Pharmaceuticals have in circulation?
The max supply of Aida Pharmaceuticals shares is 41.85B.
What is Aida Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Aida Pharmaceuticals PE Ratio is now.
What was Aida Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Aida Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the Aida Pharmaceuticals company belong to?
The Aida Pharmaceuticals sector is Healthcare.